Log in
Enquire now

List of Milestone Pharmaceuticals patents

List of Milestone Pharmaceuticals patents
List of DNA Genotek patents
List of Occipital patents
List of SatCon Technology Corporation patents
List of companies in Epic Angels's investment portfolio
List of photovoltaic system patents
Patents where
Current Assignee
Name
is
Milestone PharmaceuticalsMilestone Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9463179 Short acting phenylalkylamine calcium channel blockers and uses thereof

Patent 9463179 was granted and assigned to Milestone Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office.

Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9463179
October 11, 2016
‌
US Patent 9737503 Short acting phenylalkylamine calcium channel blockers and uses thereof

Patent 9737503 was granted and assigned to Milestone Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.

Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9737503
August 22, 2017
‌
US Patent 10117848 Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof

Patent 10117848 was granted and assigned to Milestone Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.

Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10117848
November 6, 2018
‌
US Patent 9227918 Short acting phenylalkylamine calcium channel blockers and uses thereof

Patent 9227918 was granted and assigned to Milestone Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office.

Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9227918
January 5, 2016
‌
US Patent 10010523 Short acting phenylalkylamine calcium channel blockers and uses thereof

Patent 10010523 was granted and assigned to Milestone Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.

Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10010523
July 3, 2018
‌
US Patent 10010524 Short acting phenylalkylamine calcium channel blockers and uses thereof

Patent 10010524 was granted and assigned to Milestone Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.

Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10010524
July 3, 2018
‌
US Patent 10010522 Short acting phenylalkylamine calcium channel blockers and uses thereof

Patent 10010522 was granted and assigned to Milestone Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.

Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
Milestone Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10010522
July 3, 2018
7 results
0 selected
7 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us